UK-based life sciences firm Juvenescence has announced a $100m series B financing round to support the development of artificial intelligence (AI)-based therapeutics and technologies for ageing diseases.
19 August 2019
2 August 2019
Sensyne Health, a UK-based clinical artificial intelligence (AI) technology firm, has collaborated with German pharmaceutical company Bayer to accelerate the development of new heart therapies.
16 July 2019 News
Artificial intelligence (AI) drug discovery firm Recursion Pharmaceuticals, has secured $121m in a series C funding round led by the Scottish Mortgage Investment Trust.
12 June 2019 News
Exscientia has entered a multi-target partnership with China-based GT Apeiron Therapeutics.
10 June 2019 News
Janssen Research & Development has collaborated with software solutions provider nference to leverage artificial intelligence (AI) and data sciences for the discovery and clinical development of drugs.
4 June 2019 News
Eli Lilly has formed a multi-target alliance with start-up Atomwise to support preclinical drug discovery efforts.
21 May 2019 News
Schrödinger has raised $110m during a funding round to develop its computational platform, which combines physics-based molecular simulations and machine learning for the exploration of chemical space.
1 May 2019 News
AstraZeneca has partnered with artificial intelligence (AI) company BenevolentAI to develop treatments for chronic kidney disease and idiopathic pulmonary fibrosis.
30 April 2019 News
Janssen Pharmaceutica has initiated a collaboration agreement to use Iktos’ artificial intelligence (AI) technology to accelerate small molecule drug discovery.
28 March 2019
Plummeting cost-to-compute is making machine learning and IoT applications more accessible than ever. Here's why that could benefit soceity's poorest.